Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy.
about
TLR7/TLR8 Activation Restores Defective Cytokine Secretion by Myeloid Dendritic Cells but Not by Plasmacytoid Dendritic Cells in HIV-Infected Pregnant Women and NewbornsPattern of Infectious Morbidity in HIV-Exposed Uninfected Infants and ChildrenClinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan AfricaThe Immune System of HIV-Exposed Uninfected InfantsLinking Susceptibility to Infectious Diseases to Immune System Abnormalities among HIV-Exposed Uninfected InfantsPneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children.Head circumferences of children born to HIV-infected and HIV-uninfected mothers in Zimbabwe during the preantiretroviral therapy eraHIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Era.Breastfeeding is associated with decreased pneumonia incidence among HIV-exposed, uninfected Kenyan infantsEffectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study.Altered innate immune development in HIV-exposed uninfected infants.Maternal HIV is associated with reduced growth in the first year of life among infants in the Eastern region of Ghana: the Research to Improve Infant Nutrition and Growth (RIING) Project.Morbidity in relation to feeding mode in African HIV-exposed, uninfected infants during the first 6 mo of life: the Kesho Bora studyGlobal, regional, and national estimates of pneumonia burden in HIV-infected children in 2010: a meta-analysis and modelling study.The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination.Anti-group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infectionIn-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infantsHigh-risk enteric pathogens associated with HIV infection and HIV exposure in Kenyan children with acute diarrhoeaIncreased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country.Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants.Growth and health outcomes at school age in HIV-exposed, uninfected Zambian children: follow-up of two cohorts studied in infancy.Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia.Manuscript title: Facilitators and barriers to cotrimoxazole prophylaxis among HIV exposed babies: a qualitative study from Harare, Zimbabwe.Severe Infections in HIV-Exposed Uninfected Infants Born in a European CountryEfficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.Health outcomes of HIV-exposed uninfected African infantsAltered Memory T-Cell Responses to Bacillus Calmette-Guerin and Tetanus Toxoid Vaccination and Altered Cytokine Responses to Polyclonal Stimulation in HIV-Exposed Uninfected Kenyan InfantsHIV-exposed children account for more than half of 24-month mortality in Botswana.Treatment Failures and Excess Mortality Among HIV-Exposed, Uninfected Children With PneumoniaPneumococcal Acquisition Among Infants Exposed to HIV in Rural Malawi: A Longitudinal Household Study.Managing severe infection in infancy in resource poor settingsAntibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life.HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life.Breastfeeding Is Associated with Decreased Risk of Hospitalization among HIV-Exposed, Uninfected Kenyan InfantsRisk factors for severe acute lower respiratory infections in children: a systematic review and meta-analysis.Delayed acquisition of Plasmodium falciparum antigen-specific CD4(+) T cell responses in HIV-exposed uninfected Malawian children receiving daily cotrimoxazole prophylaxisRandomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol.Family adversity and autonomic reactivity association with immune changes in HIV-affected school children.Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting.A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants.
P2860
Q24297513-C0FD27E4-241B-4F74-93BA-D4E8F8BDF317Q26747400-5F8F7235-3CBF-4E95-A092-0E2405DD05DEQ26749153-3324C461-4DFC-4738-B8C0-1994B0F116CCQ28069872-8413F1AA-FFDD-4C07-91AD-B0257440DBD5Q28077904-05B8D43E-BAC9-45CC-A9D5-FCB7FAF741FDQ30235055-D36BB43B-91E7-4F27-968F-7A8FE2BB7247Q30381646-8DA33CA9-2064-4792-BEEF-508078C4CFBAQ30383065-76644689-BE91-4CB3-8E51-92608939835AQ33854326-B4DBCCF9-CF87-4428-B7DB-AAFF9C4D5B92Q34087769-C1578D19-D55D-42FC-8502-926EDD716FDBQ34098338-53D7BE02-AE45-4CE4-8FCF-5E3FA91DBBFFQ34322790-FD710C16-E043-4928-99DD-E3D9C92E6613Q34511322-8CE21161-2562-41E5-8DB4-9BE6C171D9B9Q34563804-16CB628F-03FC-490B-8BEF-41006F333B30Q34823297-83C6165B-99D7-4E07-9330-CCCDF3CEF40EQ35042473-66FB4609-5801-44DE-B30F-94C4EFA1A452Q35097422-6D14ECB3-94B6-40B4-8402-BE6D700B4AAFQ35136908-14CC10A5-0F08-4F39-8E99-3B44E35C5D2AQ35211424-8DEF8E4D-D4A6-408A-9B51-32C7D6B51F9BQ35306303-53AFDA3A-8060-480A-9A42-6741AA038428Q35655104-2FB3D3D4-1EE9-4B81-9291-06DA9CCFF6C7Q35672554-AFAAF8BA-662C-4B9C-9A74-7EFA22FCA748Q35746871-5BC9BE44-C602-4194-84A3-242E1F4E607FQ35748668-57FA4F93-4B61-4EAB-9852-E5A2AFB37A2FQ35804683-36FAE125-F037-4D9E-98EC-601DC0137D7FQ35825690-A8D037E9-1392-4E10-B13F-30608EAE12D8Q35841753-A818CFE3-ED1F-4084-90C6-806396D041F9Q36083089-4011898D-E882-47F1-AC88-58AB80F05A68Q36377376-A095E0C3-5BFA-47E7-815F-028F4F9769C8Q36402435-7BFE41FD-EDA9-48F8-85EE-23188A75773BQ36426926-20C752E6-9E6D-433E-B5FD-84E0BB4C692CQ36504806-54AFBAF7-BF04-4FA3-8EE5-F2452F8172CAQ36727938-722A0380-3BAF-44C3-A53B-958BCFC0F700Q36746559-1DD9E0EC-61C7-45B1-AB39-2F2714BE70B3Q36811260-AD3F6D3F-1B02-4F74-A440-D584FB286A55Q36886734-FF674CE7-9B15-437C-9A23-0432C2F2B2CAQ37101067-BEFFF94B-839B-42C1-91CA-F77DFF983D79Q37315334-AAE9449C-F3BB-42E1-ADCE-41AC9CA969EAQ37350165-8451AEAC-7377-42FE-900F-AB0632C7ACD5Q37591893-4B075382-1985-4B4F-975D-503F7F7B36C2
P2860
Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Morbidity among human immunode ...... active antiretroviral therapy.
@en
Morbidity among human immunode ...... active antiretroviral therapy.
@nl
type
label
Morbidity among human immunode ...... active antiretroviral therapy.
@en
Morbidity among human immunode ...... active antiretroviral therapy.
@nl
prefLabel
Morbidity among human immunode ...... active antiretroviral therapy.
@en
Morbidity among human immunode ...... active antiretroviral therapy.
@nl
P2093
P50
P1476
Morbidity among human immunode ...... active antiretroviral therapy.
@en
P2093
Andrea Ruff
Brian Ward
Jean H Humphrey
Kuda Mutasa
Kusum Nathoo
Peter Iliff
ZVITAMBO Study Group
P356
10.1097/INF.0B013E3181ECBF7E
P577
2011-01-01T00:00:00Z